Pipeline
GSKB Pharmaceuticals, LLC is a privately held, clinical-stage neuroscience pharmaceutical company, dedicated to developing and commercializing novel oral solid formulations via the FDA 505(b)(2) abbreviated process. GSKB has a vision to become a leading innovator in neuroscience, helping to treat adults with serious psychiatric disorders, including suicide-related disorders.
GSKB will be focused on supporting physicians, nurse practitioners, and physician assistants in psychiatry who manage these patients.
| Product Candidate | Formulation | Therapeutic Area | Phase | ||||
|---|---|---|---|---|---|---|---|
| Early Development | Early Clinical | Advanced Clinical | NDA Submission | Commercialization | |||
| GSKB-001 | Oral Tablet | Psychiatry | |||||
Revolutionizing Mental Health Care
GSKB Pharmaceuticals represents a revolutionary step forward in mental health care, investigating a medication specifically designed to confront suicide-related disorders. With a bold vision and innovative science, we aim to save lives, restore hope, and redefine what’s possible in the treatment of one of the most urgent and complex challenges of our time.